Authors : G Gopu, Bharathi Vidya Jayanthi, S Palaniraj
DOI : 10.18231/j.ijpo.2022.040
Volume : 9
Issue : 2
Year : 2022
Page No : 173-176
Secretory carcinoma of breast represent a rare subtype of carcinoma breast with a incidence of less than 0.15%. Though initially thought to be limited to children. Later it was recognised that it may occur in adult as well. It has an indolent course and carries favourable prognosis. It is a slow growing tumour and it is associated with good long-term survival. Breast imaging usually mimics a benign tumour. Immunohistochemistry and cytogenetic analysis of tumour are crucial for confirmation of SBC. Currently there is no established guidelines regarding the best treatment strategy for patients with SBC. BCS with sentinel nodes biopsy is at present the first choice treatment. Further research for identification of the specific gene mutation may pave for targeted molecular therapies for this disease.
Keywords: Oncology treatment, Secretory carcinoma.